Cargando…
IMM-H004 Protects against Cerebral Ischemia Injury and Cardiopulmonary Complications via CKLF1 Mediated Inflammation Pathway in Adult and Aged Rats
(1) Background: Chemokine-like factor 1 (CKLF1) is a chemokine with potential to be a target for stroke therapy. Compound IMM-H004 is a novel coumarin derivative screened from a CKLF1/C-C chemokine receptor type 4 (CCR4) system and has been reported to improve cerebral ischemia/reperfusion injury. T...
Autores principales: | Ai, Qidi, Chen, Chen, Chu, Shifeng, Luo, Yun, Zhang, Zhao, Zhang, Shuai, Yang, Pengfei, Gao, Yan, Zhang, Xiaoling, Chen, Naihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6480569/ https://www.ncbi.nlm.nih.gov/pubmed/30987181 http://dx.doi.org/10.3390/ijms20071661 |
Ejemplares similares
-
Metabolism of IMM-H004 and Its Pharmacokinetic-Pharmacodynamic Analysis in Cerebral Ischemia/Reperfusion Injured Rats
por: Zhang, Ziqian, et al.
Publicado: (2019) -
A Narrative Review of Cancer-Related Fatigue (CRF) and Its Possible Pathogenesis
por: Yang, Songwei, et al.
Publicado: (2019) -
CZK, a novel alkaloid derivative from Clausena lansium, alleviates ischemic stroke injury through Nrf2-mediated antioxidant effects
por: Chen, Haodong, et al.
Publicado: (2023) -
C19, a C-terminal peptide of CKLF1, decreases inflammation and proliferation of dermal capillaries in psoriasis
por: Zheng, Yi, et al.
Publicado: (2017) -
CKLF as a Prognostic Biomarker and Its Association with Immune Infiltration in Hepatocellular Carcinoma
por: Li, Dan, et al.
Publicado: (2023)